Skip to content

A Randomised Control Trial of people with psychosis taking Risperdal Consta compared to people with psychosis taking Risperdal Consta and receiving Collaborative Therapy (a psychoeducational program) in a naturalistic setting

Do people with psychosis taking Risperdal Consta, who participate in Collaborative Therapy, compared to people with psychosis taking Risperdal Consta and treatment as usual, have improved treatment compliance?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000317291
Enrollment
200
Registered
2009-05-21
Start date
2008-01-02
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to see whether providing an educational program to people with psychosis who take a stable anti-psychotic medication do better than people with psychosis on a stable anti-psychotic medication who recieve usual care from their General Practitioner or case manager. We are particularly interested in people's engagement with treatment, psychiatric symptoms and everyday functioning.

Interventions

Collaborative Therapy is an 8 session psychosocial program, which provides education and coping stratagies to enhance self management of mental illness. The program will be delivered individually (1 hour) or as a group (1.5 hours) weekly for 8 weeks. Participants will receive the program either individually or as a group if: 1, 2 or 3 participants are randomised per site, or if an individual is unable to participate in a group for mental health, religious or other reasons. The duration of the i

Collaborative Therapy is an 8 session psychosocial program, which provides education and coping stratagies to enhance self management of mental illness. The program will be delivered individually (1 hour) or as a group (1.5 hours) weekly for 8 weeks. Participants will receive the program either individually or as a group if: 1, 2 or 3 participants are randomised per site, or if an individual is unable to participate in a group for mental health, religious or other reasons. The duration of the intervention is 8 weeks.

Sponsors

Prof. David Castle
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Age 18 – 65 years Currently taking Risperdal Consta (must have been on consta for a minimum of 6 weeks). Able to converse in English without an interpreter Absence of developmental disability or amnestic syndrome that would impair ability to learn from the intervention.

Exclusion criteria

Age under 18 years Not taking Risperdal Consta Unable to converse in English without an interpreter Presence of developmental disability or amnestic syndrome that would impair ability to learn from the intervention

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026